[Current situation of pediatric liver transplantation in Chile. Inequities associated with the MELD/PELD prioritization system].

Situación actual del trasplante hepático pediátrico por hepatopatías crónicas en Chile: Inequidades asociadas a la priorización por sistema MELD/PELD.

Journal

Revista medica de Chile
ISSN: 0717-6163
Titre abrégé: Rev Med Chil
Pays: Chile
ID NLM: 0404312

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 26 03 2020
accepted: 14 09 2020
entrez: 5 1 2021
pubmed: 6 1 2021
medline: 26 1 2021
Statut: ppublish

Résumé

The Chilean allocation system for liver transplantation (LT) uses the MELD/PELD score to prioritize candidates on the waiting list. To assess if the Chilean allocation system for LT is equitable for pediatric candidates compared to their adult counterparts. We used the Public Health Institute's registry between October 2011 and December 2017. We analyzed candidates with chronic hepatic diseases listed for LT. The primary outcome was the cadaveric liver transplantation (CLT) rate. Secondary outcomes were death or disease progression in the waiting list and living donor liver transplant (LDLT) rate. We analyzed 122 pediatric and 735 adult candidates. Forty one percent of pediatric candidates obtained a CLT compared to 48% of adults (p = NS). Among patients aged under two years of age, the access to CLT on the waiting list there was 28% of CLT, compared to 48% in adults (p = 0.001). Fifty-seven percent of candidates aged under two years were listed for cholestatic diseases, obtaining a CLT in 18% and requiring a LDLT in 49%. The median time in the waiting list for CLT was 5.9 months in pediatric candidates and 5.1 in adults, while the median time to death in the waiting list was 2.8 and 5.6 months, respectively. The mortality rate at one year in candidates under two years old was 38.1% compared to 32.5% in adults. Pediatric candidates with chronic liver diseases, especially under two years of age, have greater access difficulties to CLT than adults. Half of the pediatric candidates die on the waiting list before three months. The mortality among candidates under two years of age in the waiting list is excessively high.

Sections du résumé

BACKGROUND BACKGROUND
The Chilean allocation system for liver transplantation (LT) uses the MELD/PELD score to prioritize candidates on the waiting list.
AIM OBJECTIVE
To assess if the Chilean allocation system for LT is equitable for pediatric candidates compared to their adult counterparts.
MATERIAL AND METHODS METHODS
We used the Public Health Institute's registry between October 2011 and December 2017. We analyzed candidates with chronic hepatic diseases listed for LT. The primary outcome was the cadaveric liver transplantation (CLT) rate. Secondary outcomes were death or disease progression in the waiting list and living donor liver transplant (LDLT) rate.
RESULTS RESULTS
We analyzed 122 pediatric and 735 adult candidates. Forty one percent of pediatric candidates obtained a CLT compared to 48% of adults (p = NS). Among patients aged under two years of age, the access to CLT on the waiting list there was 28% of CLT, compared to 48% in adults (p = 0.001). Fifty-seven percent of candidates aged under two years were listed for cholestatic diseases, obtaining a CLT in 18% and requiring a LDLT in 49%. The median time in the waiting list for CLT was 5.9 months in pediatric candidates and 5.1 in adults, while the median time to death in the waiting list was 2.8 and 5.6 months, respectively. The mortality rate at one year in candidates under two years old was 38.1% compared to 32.5% in adults.
CONCLUSIONS CONCLUSIONS
Pediatric candidates with chronic liver diseases, especially under two years of age, have greater access difficulties to CLT than adults. Half of the pediatric candidates die on the waiting list before three months. The mortality among candidates under two years of age in the waiting list is excessively high.

Identifiants

pubmed: 33399701
pii: S0034-98872020000901261
doi: 10.4067/S0034-98872020000901261
pii:
doi:

Types de publication

Journal Article

Langues

spa

Sous-ensembles de citation

IM

Pagination

1261-1270

Auteurs

Luis Antonio Díaz (LA)

Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile.

Marisol López (M)

Departamento de Pediatría, Pontificia Universidad Católica de Chile, Santiago, Chile.

Priscila Sin (P)

División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Rodrigo Wolff (R)

Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile.

Gloria González (G)

Hospital Dr. Luis Calvo Mackenna, Santiago, Chile.

María Paz Muñoz (MP)

Hospital Dr. Luis Calvo Mackenna, Santiago, Chile.

Mario Uribe (M)

Hospital Dr. Luis Calvo Mackenna, Santiago, Chile.

Álvaro Ananias (Á)

Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Ignacio Bezama (I)

Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Nicolás Zañartu (N)

Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Erwin Buckel (E)

Clínica Las Condes, Santiago, Chile.

Franco Innocenti (F)

Clínica Sanatorio Alemán, Concepción, Chile.

Juan Carlos Pattillo (JC)

División de Cirugía, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Nicolás Jarufe (N)

Clínica Las Condes, Santiago, Chile.

Jorge Martínez (J)

División de Cirugía, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Juan Francisco Guerra (JF)

MedStar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington D.C., Estados Unidos de Norteamérica.

Susana Elgueta (S)

Instituto de Salud Pública, Santiago, Chile.

Juan Cristóbal Gana (JC)

División de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH